Dean OM - Search Results

1

Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.

Wrobel AL, Köhler-Forsberg O, Sylvia LG, Russell SE, Dean OM, Cotton SM, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis MG, Kocsis JH, Friedman ES, Ketter TA, Shelton RC, Ostacher MJ, Iosifescu DV, Berk M, Turner A, Nierenberg AA. Wrobel AL, et al. Among authors: dean om. Acta Psychiatr Scand. 2022 Jun;145(6):615-627. doi: 10.1111/acps.13420. Epub 2022 Mar 11. Acta Psychiatr Scand. 2022. PMID: 35243620 Free PMC article. Clinical Trial.

2

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

Ng F, Berk M, Dean O, Bush AI. Ng F, et al. Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21. Int J Neuropsychopharmacol. 2008. PMID: 18205981 Free article. Review.

3

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI. Berk M, et al. Biol Psychiatry. 2008 Sep 1;64(5):361-8. doi: 10.1016/j.biopsych.2008.03.004. Epub 2008 Apr 23. Biol Psychiatry. 2008. PMID: 18436195 Clinical Trial.

4

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI. Berk M, et al. Biol Psychiatry. 2008 Sep 15;64(6):468-75. doi: 10.1016/j.biopsych.2008.04.022. Epub 2008 Jun 5. Biol Psychiatry. 2008. PMID: 18534556 Clinical Trial.

5

Glutathione: a novel treatment target in psychiatry.

Berk M, Ng F, Dean O, Dodd S, Bush AI. Berk M, et al. Trends Pharmacol Sci. 2008 Jul;29(7):346-51. doi: 10.1016/j.tips.2008.05.001. Epub 2008 Jun 4. Trends Pharmacol Sci. 2008. PMID: 18538422 Review.

6

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. Dodd S, et al. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. Expert Opin Biol Ther. 2008. PMID: 18990082 Review.

7

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Dean O, et al. Behav Brain Res. 2009 Mar 2;198(1):258-62. doi: 10.1016/j.bbr.2008.11.017. Epub 2008 Nov 18. Behav Brain Res. 2009. PMID: 19061918

8

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M. Dean OM, et al. Curr Med Chem. 2009;16(23):2965-76. doi: 10.2174/092986709788803060. Curr Med Chem. 2009. PMID: 19689277 Review.

9

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.

Berk M, Jeavons S, Dean OM, Dodd S, Moss K, Gama CS, Malhi GS. Berk M, et al. Among authors: dean om. CNS Spectr. 2009 Jul;14(7):357-60. doi: 10.1017/s1092852900023002. CNS Spectr. 2009. PMID: 19773711 Free article.

10

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. Magalhães PV, et al. Among authors: dean om. J Affect Disord. 2011 Mar;129(1-3):317-20. doi: 10.1016/j.jad.2010.08.001. Epub 2010 Aug 30. J Affect Disord. 2011. PMID: 20800897 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page